CHOSA Oncology’s CCO and board member Claus Frisenberg Pedersen visits Västra Hamnen and discusses the latest developments, what benefit CHOSA brings to cancer patients and how the company creates shareholder value. CHOSA is exercising its TO2 warrants during the period July 1 – 14, the subscription price is 0.78 SEK per share. The interview is moderated by Västra Hamnen’s chief analyst Martin Dominique.
LÄS MER
